SEC Form 4 · accession 0000320187-18-000175

NIKE, Inc. · NKE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Sep 19, 2018

Accepted (ET)

Sep 20, 2018 · 4:53 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000320187

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class B Common Stock^F1	Sep 19, 2018	M	14,200	$15.79	A	26,963	D
Class B Common Stock^F1,F2	Sep 19, 2018	S	14,200	$84.9599	D	12,763	D
Class B Common Stock^F1	Sep 19, 2018	M	1,800	$15.79	A	14,563	D
Class B Common Stock^F1,F3	Sep 19, 2018	S	1,800	$85.7978	D	12,763	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F1,F4	$15.79	Sep 19, 2018	M	14,200	D	—	Sep 22, 2018	Class B Common Stock	14,200	1,800	D
Non-Qualified Stock Option (right to buy)^F1,F4	$15.79	Sep 19, 2018	M	1,800	D	—	Sep 22, 2018	Class B Common Stock	1,800	0	D

F1Exercise and sale was pursuant to an approved 10b5-1 trading plan. Pursuant to Company policy, market transactions in Company stock by officers and directors are permitted only after the second full trading day after the public release of quarterly earnings and ending on the last day of the second month of the following fiscal quarter, except pursuant to approved 10b5-1 trading plans.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.415 to $85.41, inclusive. The reporting person undertakes to provide NIKE, Inc., any security holder of NIKE, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3The price reported in Column 4 is a weighted average price. These shares have been sold in multiple transactions at prices ranging from $85.45 to $85.85.
F4Option granted on 09/22/2008 and became exercisable with respect to 100% of the shares on the date of the first annual meeting of shareholders of the Company held after the Grant Date.